missing translation for 'onlineSavingsMsg'
Learn More

Gibco™ RPMI 1640 Medium, powder

Product Code. 11554506 Shop All Gibco Products
Change view
Click to view available options
Quantity:
10 L
1 L
50 L
Unit Size:
1 L
10 L
50 L
3 product options available for selection
Product selection table with 3 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity Unit Size
11554506 50 L 50 L
10655953 1 L 1 L
11544506 10 L 10 L
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 3 options available.
3 options
Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen
Artikelnummer. 11554506 Lieferant Gibco™ Lieferanten-Nr. 51800043
Menge Preis
1 148.00 EUR / 50 L
50 123.60 EUR / 50 L
10 130.10 EUR / 50 L
 Restricted Item
Estimated Shipment: 10-12-2026
Zum Warenkorb hinzufügen

missing translation for 'validMainframeMsg'

Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen

RPMI 1640 Medium, powder

Roswell Park Memorial Institute (RPMI) 1640 medium was originally developed to culture human leukemic cells in suspension and as a monolayer. RPMI 1640 has since been found suitable for a variety of mammalian cells including HeLa, Jurkat, MCF-7, PC12, PBMC, astrocytes, and carcinomas. Life Technologies offers a variety of Gibco™ RPMI 1640 modifications for a range of cell culture applications.

Gibco™ RPMI 1640 is unique from other media because it contains the reducing agent glutathione and high concentrations of vitamins. RPMI 1640 contains biotin, vitamin B12, and PABA which are not found in Eagle's Minimal Essential Medium or Dulbecco's Modified Eagle Medium. In addition, the vitamins inositol and choline are present in very high concentrations.

Product Intended Use
For in vitro diagnostic use. CAUTION: Not for human or animal therapeutic use. Uses other than the intended use may be a violation of local law. Customers using Gibco™ RPMI 1640 in a manufacturing process, who have a submission with the FDA, may request a letter of authorization from Life Technologies to reference our Type II Drug Master File (DMF).

cGMP Manufacturing and Quality System
Gibco™ RPMI 1640 is manufactured at a cGMP compliant facility, located in Paisley, Scotland, UK. The facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standard. For supply chain continuity, Life Technologies offers a comparable Gibco™ RPMI 1640 product made in our Grand Island facility (31800-089). This facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standards.

RPMI 1640 contains no proteins, lipids, or growth factors. Therefore, RPMI 1640 requires supplementation, commonly with 10% Fetal Bovine Serum (FBS). RPMI 1640 uses a sodium bicarbonate buffer system (2.0 g/L) and therefore requires a 5-10% CO2 environment to maintain physiological pH.

Powder forms of Gibco™ L-15 cell culture medium require sodium bicarbonate supplementation pH adjustment, and filtration at the time of preparation.
TRUSTED_SUSTAINABILITY

Spezifikation

Form Powder
Product Type Roswell Park Memorial Institute (RPMI) 1640 Medium
With Additives Glutamine, Phenol Red
Without Additives No HEPES, No Sodium Pyruvate, No Sodium Bicarbonate
For Use With (Application) Mammalian cell culture
Quantity 50 L
Certifications/Compliance ISO 13485 standards, FDA
pH 7.4 to 7.6
Content And Storage 2 to 8°C
Description Roswell Park Memorial Institute (RPMI) 1640 Medium, 50L, Powder, 7.4 to 7.6 pH, With L-Glutamine, Phenol Red, 36 Months Shelf Life, 230 to 280mOsm/kg Osmolality, For Mammalian Cell Culture
Name des Produkts
Wählen Sie ein Thema

Indem Sie auf Absenden klicken, erklären Sie sich damit einverstanden, dass Fisher Scientific sich mit Ihnen in Verbindung setzen kann, um Ihr Feedback in diesem Formular zu bearbeiten. Wir werden Ihre Informationen nicht für andere Zwecke weitergeben. Alle bereitgestellten Kontaktinformationen werden in Übereinstimmung mit unserer Datenschutzrichtlinie aufbewahrt. Datenschutzrichtlinie.